Comparison of the overall survival of different treatment methods in patients with Muscle-invasive bladder cancer: A retrospective study
Urologia Journal · 2024
DOI: 10.1177/03915603241256009 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Urologia Journal, 2024. Verfasst von Hamid Pakmanesh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, Iran. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Neoplasm Invasiveness, Cystectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objectives
Bladder-Sparing Approach was presented in patients who are not willing or not suitable for Radical Cystectomy (RC). There have been inconsistencies in the literature regarding the comparison of survival rates of these two methods. Our objective is to evaluate the survival rate of patients with muscle-invasive bladder cancer (MIBC) undergoing different treatment methods.
Design
Retrospective cross-sectional study.
Setting
A secondary care, multicenter study in Kerman, Iran 2008 to 2016.
Participants
All 200 patients who were diagnosed with Muscle Invasive Bladder Cancer and were admitted to our hospitals. Patients with inaccessible medical files and patients with pathologies other than TCC were excluded. Main outcome measures: Radical cystectomy and different methods of bladder preservation were compared based on their survival rate.
Interventions
Radical cystectomy or bladder preservation Results: Overall survival of the patients was 2 years [95% CI: 1.37–2.63]. The overall 5-year survival rate of patients with MIBC was 32%. Having a 6.4 years overall survival, the RC group showed the highest survival compared with others ( p = 0.01); the overall survival of patients undergoing TMT, TURT, chemotherapy, or radiotherapy monotherapy was 3.15 years [95% CI: 2.242–4.061], 4.06 [95% CI: 3.207–4.931], 2.58 [95% CI: 1.767–3.399], and 3.14 [95% CI: 1.614–4.672] years, respectively. Patients younger than 65 undergoing RC had an overall survival of 7 years, compared with 2 years for the TMT group. ( p = 0.0001).
Conclusions
The Bladder-Preservation method, as a replacement for RC, showed a lower overall survival rate in our study. A prospective randomized clinical trial may declare the best treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, School of Medicine, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, Iran.
- Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
- Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran.
ORCID-Profile: Hamid Pakmanesh, Mohammadamin Hesamarefi
Zitieren
APA
Pakmanesh, H., Khajehsalimi, A., Hesamarefi, M., Ebadzadeh, M. R., Bazrafshan, A., Malekpourafshar, R., Mirzaei, M., Daneshpajouh, A., Shahesmaeili, A., & Eslami, N. (2024). Comparison of the overall survival of different treatment methods in patients with Muscle-invasive bladder cancer: A retrospective study. Urologia Journal. https://doi.org/10.1177/03915603241256009
Vancouver
Pakmanesh H, Khajehsalimi A, Hesamarefi M, Ebadzadeh MR, Bazrafshan A, Malekpourafshar R, et al. Comparison of the overall survival of different treatment methods in patients with Muscle-invasive bladder cancer: A retrospective study. Urologia Journal. 2024. doi:10.1177/03915603241256009
BibTeX
@article{Pakmanesh2024,
author = {Pakmanesh, Hamid and Khajehsalimi, Azadeh and Hesamarefi, Mohammadamin and Ebadzadeh, Mohamad Reza and Bazrafshan, Azam and Malekpourafshar, Reza and Mirzaei, Mahboubeh and Daneshpajouh, Azar and Shahesmaeili, Armita and Eslami, Nazanin},
title = {Comparison of the overall survival of different treatment methods in patients with Muscle-invasive bladder cancer: A retrospective study},
journal = {Urologia Journal},
year = {2024},
doi = {10.1177/03915603241256009}
}
EUVIMED